Drawing for SUPERHERO

USPTO serial 85030326

SUPERHERO

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
COOPER, CHRISTINE H
Law office
TMO LAW OFFICE 113

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SUPERHERO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Raj Abhyanker

RAJ ABHYANKER RAJ ABHYANKER LLP1580 W EL CAMINO REAL STE 8MOUNTAIN VIEW, CA 94040-2462UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Consulting services in the field of health and wellness for consumersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 15, 2011MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Aug 15, 2011ABN1ABANDONMENT - EXPRESS MAILED—
Aug 12, 2011EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Mar 16, 2011RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 8, 2011ALIEASSIGNED TO LIE—
Aug 24, 2010GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 24, 2010GNSLLETTER OF SUSPENSION E-MAILED—
Aug 24, 2010CNSLSUSPENSION LETTER WRITTEN—
Aug 24, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Aug 24, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 24, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 24, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 17, 2010DOCKASSIGNED TO EXAMINER—
May 10, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance